KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bio-Rad Laboratories (BIO) Cost of Revenue (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Cost of Revenue for 17 consecutive years, with $348.0 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 6.88% to $348.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 4.68% year-over-year, with the annual reading at $1.2 billion for FY2025, 4.69% up from the prior year.
  • Cost of Revenue for Q4 2025 was $348.0 million at Bio-Rad Laboratories, up from $309.6 million in the prior quarter.
  • The five-year high for Cost of Revenue was $348.0 million in Q4 2025, with the low at $279.4 million in Q1 2025.
  • Average Cost of Revenue over 5 years is $309.7 million, with a median of $309.6 million recorded in 2021.
  • The sharpest move saw Cost of Revenue grew 28.88% in 2021, then dropped 11.06% in 2024.
  • Over 5 years, Cost of Revenue stood at $334.3 million in 2021, then dropped by 0.35% to $333.2 million in 2022, then dropped by 5.51% to $314.8 million in 2023, then grew by 3.43% to $325.6 million in 2024, then grew by 6.88% to $348.0 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $348.0 million, $309.6 million, and $306.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.